Stocks · Health care · Pharmaceutical Preparations

Inventiva S.A.

IVA Clue Score56
France Fiscal year ends December CIK 0001756594
$3.12 -1.27% Close, 12 Oct 2026
Price $3.12 −77.19% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 10 Jul 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2018Revenue3.2Operating income−32.9Net income−33.0Fiscal year 2019Revenue7.0 +118.9%Operating income−30.3Net income−30.2EPS, diluted−1.28Fiscal year 2020Revenue0.4 −94.7%Operating income−29.7Net income−33.6EPS, diluted−0.99Fiscal year 2021Revenue4.2 +1,027.4%Operating income−52.1Net income−49.6EPS, diluted−1.27Fiscal year 2022Revenue12.2 +190.4%Operating income−57.1Net income−54.3EPS, diluted−1.31Fiscal year 2023Revenue17.5 +43.5%Operating income−102.7Net income−110.4EPS, diluted−2.43Fiscal year 2024Revenue9.2 −47.4%Operating income−97.6Net income−184.2EPS, diluted−3.08
FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Revenue 3.2 7.0 0.4 4.2 12.2 17.5 9.2
Growth +118.9% −94.7% +1,027.4% +190.4% +43.5% −47.4%
Operating income −32.9 −30.3 −29.7 −52.1 −57.1 −102.7 −97.6
Net income −33.0 −30.2 −33.6 −49.6 −54.3 −110.4 −184.2
Growth
EPS, diluted n/a −1.28 −0.99 −1.27 −1.31 −2.43 −3.08
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2018Operating margin−1,029.2%Net margin−1,032.7%Fiscal year 2019Operating margin−433.2%Net margin−431.8%Fiscal year 2020Operating margin−7,988.7%Net margin−9,037.4%Fiscal year 2021Operating margin−1,242.6%Net margin−1,183.5%Fiscal year 2022Operating margin−468.9%Net margin−445.6%Fiscal year 2023Operating margin−587.7%Net margin−631.8%Fiscal year 2024Operating margin−1,060.6%Net margin−2,002.7%
FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Operating margin −1,029.2% −433.2% −7,988.7% −1,242.6% −468.9% −587.7% −1,060.6%
Net margin −1,032.7% −431.8% −9,037.4% −1,183.5% −445.6% −631.8% −2,002.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2018Operating cash flow−34.2Fiscal year 2019Operating cash flow−28.4Fiscal year 2020Operating cash flow−30.6Fiscal year 2021Operating cash flow−47.6Fiscal year 2022Operating cash flow−44.9Fiscal year 2023Operating cash flow−81.6Fiscal year 2024Operating cash flow−85.9
FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Operating cash flow −34.2 −28.4 −30.6 −47.6 −44.9 −81.6 −85.9

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash and securitiesTotal debt
Fiscal year 2018Cash and securities56.7Total debt0.2Net cash (debt)56.5Shareholders’ equity61.6Debt to equity0.00Fiscal year 2019Cash and securities35.8Total debt0.1Net cash (debt)35.7Shareholders’ equity41.4Debt to equity0.00Fiscal year 2020Cash and securities105.7Total debt10.1Net cash (debt)95.6Shareholders’ equity111.2Debt to equity0.09Fiscal year 2021Cash and securities86.6Total debt8.8Net cash (debt)77.7Shareholders’ equity88.9Debt to equity0.10Fiscal year 2022Cash and securities86.7Total debt28.7Net cash (debt)58.1Shareholders’ equity45.5Debt to equity0.63Fiscal year 2023Cash and securities26.9Shareholders’ equity−32.0Fiscal year 2024Cash and securities96.6Shareholders’ equity−106.6
FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Cash and securities 56.7 35.8 105.7 86.6 86.7 26.9 96.6
Total debt 0.2 0.1 10.1 8.8 28.7 n/a n/a
Net cash (debt) 56.5 35.7 95.6 77.7 58.1 n/a n/a
Shareholders’ equity 61.6 41.4 111.2 88.9 45.5 −32.0 −106.6
Debt to equity 0.00 0.00 0.09 0.10 0.63 n/a n/a

In millions of EUR, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2024 · 10-K

Income statement

In millions of EUR, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024
Revenue and profit
3.2 7.0 0.4 4.2 12.2 17.5 9.2
Growth +118.9% −94.7% +1,027.4% +190.4% +43.5% −47.4%
31.8 33.8 23.7 48.5 60.5 110.0 90.9
6.0 6.1 8.5 11.2 12.9 13.8 15.8
−32.9 −30.3 −29.7 −52.1 −57.1 −102.7 −97.6
Growth
n/a 0.0 0.0 0.4 −0.0 0.6 0.3
−33.0 −30.2 −33.6 −49.6 −54.3 −110.4 −184.2
Growth
Per share
n/a −1.28 −0.99 −1.27 −1.31 −2.43 −3.08
n/a −1.28 −0.99 −1.27 −1.31 −2.43 −3.08
Growth
n/a 23.5 33.9 39.2 41.4 45.4 59.8
20.5 23.5 33.9 39.2 41.4 45.4 59.8
Growth +14.5% +44.0% +15.6% +5.8% +9.4% +31.8%

Shown in EUR as filed; the screener converts to dollars.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 5.6% a year over five years.
  • The diluted share count rose 154.2% in five years, which is dilution.
  • Operating margin is down 627.5 points on five years ago, at -1,060.6%.
  • A net loss in 7 of 7 years on file.